POTASSIUM CITRATE
NDC 31722-132, Potassium Citrate, tablet, extended release, from Camber Pharmaceuticals, Inc.
- Product NDC
- 31722-132
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214420
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POTASSIUM CITRATE15 meq/1
Pharmacologic classes
Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-132-01 | 31722013201 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-132-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ea933654-e8d2-4662-9a9a-4a6d79a9fb20NADAC price for package 31722013201
GET /v1/drugs/nadac/31722013201
Use it
Look up 31722-132 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.